Gavreto is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Genentech, Inc.. The primary component is Pralsetinib.
Product ID | 50242-210_05cc6c61-4048-4f99-88e3-f01cb828b21c |
NDC | 50242-210 |
Product Type | Human Prescription Drug |
Proprietary Name | Gavreto |
Generic Name | Pralsetinib |
Dosage Form | Capsule |
Route of Administration | ORAL |
Marketing Start Date | 2020-09-04 |
Marketing Category | NDA / |
Application Number | NDA213721 |
Labeler Name | Genentech, Inc. |
Substance Name | PRALSETINIB |
Active Ingredient Strength | 100 mg/1 |
NDC Exclude Flag | N |
Listing Certified Through | 2022-12-31 |
Marketing Start Date | 2021-07-01 |
NDC Exclude Flag | N |
Sample Package? | N |
NDC | Brand Name | Generic Name |
---|---|---|
50242-210 | Gavreto | Pralsetinib |
72064-210 | GAVRETO | pralsetinib |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
GAVRETO 90546447 not registered Live/Pending |
Blueprint Medicines Corporation 2021-02-25 |
GAVRETO 90025140 not registered Live/Pending |
Blueprint Medicines Corporation 2020-06-29 |
GAVRETO 88492520 not registered Live/Pending |
Blueprint Medicines Corporation 2019-06-27 |